Top

Tag: Medicare


Industry Focus Areas, Medical, Regulations

Drugmakers Look to Curb Medicare’s New Power to Negotiate Lower Drug Prices

October 20, 2022

Via: The Wall Street Journal

Drugmakers are trying to blunt Medicare’s newfound power to negotiate medicine prices while coping with internal industry disputes and ebbing influence in Washington, D.C. Under the Inflation Reduction Act, Congress gave Medicare, the country’s biggest buyer of prescription drugs, the […]